Literature DB >> 2276050

Spongiform encephalopathy transmitted experimentally from Creutzfeldt-Jakob and familial Gerstmann-Sträussler-Scheinker diseases.

H F Baker1, L W Duchen, J M Jacobs, R M Ridley.   

Abstract

A comparison was made of the effects of experimental intracerebral inoculation into marmosets of brain homogenates from a case of Creutzfeldt-Jakob disease (CJD) and from a member of the Wo. family with cerebral amyloid and spongiform encephalopathy--the Gerstmann-Sträussler-Scheinker (GSS) syndrome. All the inoculated marmosets developed spongiform encephalopathy (SE) after incubation times of 20-23 months in the CJD group and 25-32 months in the GSS group. Subsequent passage from 1 affected animal in each group resulted in SE developing after 17 months incubation. In every animal inoculated with CJD or GSS material and in the 2 passage experiments the most severely affected region of the brain was the thalamus which in all cases was almost totally occupied by vacuoles. Other grey matter masses were less severely and less consistently affected. Vacuolation was observed in the cerebellar granule cell layer as well as in the molecular layer and the brain stem was finely vacuolated in all cases. There were only minor and inconsistent differences between the disease transmitted from CJD compared with GSS and some differences between the original transmissions and the SE caused by passaged inocula. Severe astrocytic gliosis accompanied the spongiform changes but no amyloid was identified in any of the marmosets with experimentally transmitted disease. The pathogenesis of the spongiform change in the thalamus was studied in a series of marmosets by light and electron microscopy 3-22 months after the intracerebral inoculation of CJD or GSS homogenates and was compared with controls. Dilated irregularly-shaped cisternae and the large complex vacuoles typical of SE, present in abundance after 18 and 22 months incubation, were considered most probably to be derived from cisternae of neuronal smooth endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276050     DOI: 10.1093/brain/113.6.1891

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  12 in total

Review 1.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

2.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

3.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

4.  Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae.

Authors:  M Jeffrey; J R Scott; A Williams; H Fraser
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.

Authors:  P Parchi; S G Chen; P Brown; W Zou; S Capellari; H Budka; J Hainfellner; P F Reyes; G T Golden; J J Hauw; D C Gajdusek; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

6.  Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.

Authors:  Patrick Tremblay; Haydn L Ball; Kiyotoshi Kaneko; Darlene Groth; Ramanujan S Hegde; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner; Jiri G Safar
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases.

Authors:  Anne-Gaëlle Biacabe; Jorg G Jacobs; Anna Bencsik; Jan P M Langeveld; Thierry G M Baron
Journal:  Prion       Date:  2007-01-11       Impact factor: 3.931

8.  Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.

Authors:  Laura Pirisinu; Romolo Nonno; Elena Esposito; Sylvie L Benestad; Pierluigi Gambetti; Umberto Agrimi; Wen-Quan Zou
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  At the centre of neuronal, synaptic and axonal pathology in murine prion disease: degeneration of neuroanatomically linked thalamic and brainstem nuclei.

Authors:  Renata Reis; Edel Hennessy; Caoimhe Murray; Éadaoin W Griffin; Colm Cunningham
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-30       Impact factor: 8.090

Review 10.  Transmissibility of Gerstmann-Sträussler-Scheinker syndrome in rodent models: New insights into the molecular underpinnings of prion infectivity.

Authors:  Romolo Nonno; Michele Angelo Di Bari; Umberto Agrimi; Laura Pirisinu
Journal:  Prion       Date:  2016-11       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.